Virax Biolabs Group Ltd. Class A (VRAX) Revenue
171 Followers
Virax Biolabs Group Ltd. Class A Revenue
Virax Biolabs Group Ltd. Class A had a revenue of 12.42K in the quarter ending Mar 31, 2026, with 672.57%. This bring the company's revenue in the last twelve months to 14.03K, Increased 369.89%. In the fiscal year ending Mar 31, 2026, Virax Biolabs Group Ltd. Class A had annual revenue of 12.42K with 96.22% growth.
- Revenue (ttm)
- 14.03K
- Revenue Growth
- 96.22%
- P/S Ratio
- 127.75
- Revenue/Employee
- $478
- Employees
- 26
- Market Cap
- $1.59M
Revenue Chart
Virax Biolabs Group Ltd. Class A Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.42K | 6.09K | 96.22% |
| Mar 31, 2025 | 6.33K | -150.09K | -95.95% |
| Mar 31, 2024 | 156.42K | 156.42K | ― |
| Sep 30, 2022 | 0.00 | -123.82K | -100.00% |
| Mar 31, 2021 | 123.82K | 23.94K | 23.97% |
| Mar 31, 2020 | 99.88K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.